An Dr. Edwin P. Alyea

Déanann an Dr. Edwin P. Alyea speisialtóireacht i gcóireáil othair ailse fola atá ag smaoineamh ar thrasphlandú gascheall nó smeara. Le 20 bliain anuas, tá dul chun cinn suntasach déanta maidir le trasphlandú, rud a d’eascair torthaí níos fearr. Áirítear leis na dul chun cinn seo an cumas dáileoga ceimiteiripe níos ísle a úsáid chun tocsaineacht in othair a laghdú, chomh maith le modhanna chun an dóchúlacht go dtarlóidh athiompú a laghdú. Tá suim agam leigheasanna agus teicnící núíosacha a úsáid chun torthaí a fheabhsú tar éis trasphlandú gascheall le haghaidh urchóideacht fola. Tá sé ríthábhachtach comhoibriú le hothair chun a spriocanna cóireála agus an beart is fearr a shainiú. Le blianta fada tar éis a n-trasphlandúcháin, ba bhreá liom a bheith ag obair le hothair agus lena dteaghlaigh.

Deimhniú Boird

Bord Meiriceánach Med Inmheánach, Oinceolaíocht Leighis

Comhaltacht

Oinceolaíocht Leighis, Institiúid Ailse Dana-Farber (Massachusetts), 1992-1995

Cónaitheacht

Leigheas Inmheánach, Brigham agus Ospidéal na mBan (Massachusetts), 1989-1992

oideachas

MD, Ollscoil Dhiúc, 1989

• Smeara Fásta agus Trasphlandú Gascheall
• Trasphlandú Uathlógach
• Trasphlandú Allogeneic
• Trasphlandú Syngeneic

• Hourigan, Christopher S., Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, et al. “Impact of Conditioning Intensity of Allogeneic Transplantation for Leuceem Géarmhéideach With Genomic Evidence of Residual Disease.” J Clin Oncol 38, uimh. 12 (20 Aibreán, 2020): 1273–83. https://doi.org/10.1200/JCO.19.03011 .
• Soiffer, Robert J., Haesook T. Kim, Joseph McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M. Patnaik, Witold Rybka, et al. “Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.” J Clin Oncol 35, uimh. 36 (20 Nollaig, 2017): 4003–11. https://doi.org/10.1200/JCO.2017.75.8177.
• Liu, Hien Duong, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, et al. “Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.” Trasphlandú Smeara Fola 23, uimh. 5 (Bealtaine 2017): 767–75. https://doi.org/10.1016/j.bbmt.2017.01.078.
• Scott, Bart L., Marcelo C. Pasquini, Brent R. Logan, Juan Wu, Steven M. Devine, David L. Porter, Richard T. Maziarz, et al. “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.” J Clin Oncol 35, uimh. 11 (10 Aibreán, 2017): 1154–61. https://doi.org/10.1200/JCO.2016.70.7091 .
• Shaffer, Brian C., Kwang Woo Ahn, Zhen-Huan Hu, Taiga Nishihori, Adriana K. Malone, David Valcárcel, Michael R. Grunwald, et al. “Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.” J Clin Oncol 34, uimh. 16 (1 Meitheamh, 2016): 1864–71. https://doi.org/10.1200/JCO.2015.65.0515.
• Devine, Steven M., Kouros Owzar, William Blum, Flora Mulkey, Richard M. Stone, Jack W. Hsu, Richard E. Champlin, et al. “Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.” J Clin Oncol 33, uimh. 35 (10 Nollaig, 2015): 4167–75. https://doi.org/10.1200/JCO.2015.62.7273.
• Jacobson, Caron A., Lixian Sun, Haesook T. Kim, Sean M. McDonough, Carol G. Reynolds, Michael Schowalter, John Koreth, et al. “Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.” Trasphlandú Smeara Fola 20, uimh. 5 (Bealtaine 2014): 668–75. https://doi.org/10.1016/j.bbmt.2014.01.021.
• Cutler, Corey, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, et al. “Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.” Fola 122, uimh. 8 (22 Lúnasa, 2013): 1510–17. https://doi.org/10.1182/blood-2013-04-495895.
• Porcheray, Fabrice, David B. Miklos, Blair H. Floyd, Stefanie Sarantopoulos, Roberto Bellucci, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea, Jerome Ritz, and Emmanuel Zorn. “Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.” Athphlandáil 92, uimh. 3 (15 Lúnasa, 2011): 359–65. https://doi.org/10.1097/TP.0b013e3182244cc3 .